Rapydan Topical Anaesthesia for Arterial Cannulation

NCT01494311 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Arterial Catheterization

Interventions

DRUG: Lidocaine/tetracaine patch
DRUG: Placebo Patch
DRUG: Subcutaneous injection of 0.5 ml Lidocain 1%
DRUG: Subcutaneous injection of saline

Sponsor

Medical University of Vienna

Collaborators

[object Object]
[object Object]